Friday, November 29, 2019 12:00:43 AM
I remember a few years ago when Hillary was running, she made one tweet about lowering drugs costs by going after big pharma and that sector took an immediate hit for a while.
I think everyone can agree that drugs prices are to high.
I think everyone can agree that we want to make big profits in pharma, though.
Now, Trump is talking about lowering prices.
Pharma has big ups and downs, based on the FDA and it costs a lot to bring a drug to market.
How will lowering the costs of drugs, screw over our profits? Especially, considering Trump/congress/whoever, still probably won't fix the entire problem of the high cost of bringing drugs to market.
I know we want a pharma profit here, but we also don't want high drug prices, if we or family or friends need meds.
Is the profit going to be taken out of pharma?
How can the high cost of bringing drugs to market still generate a profit for investors, when the drugs might be sold for less, that would mean a lower profit for all, right?
Recent ACAD News
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/15/2024 08:05:00 PM
- Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day • Business Wire • 03/13/2024 08:05:00 PM
- Oracle Soars 13% With Exceptional Growth and Boosts Nvidia Shares With Collaboration Announcement, and More • IH Market News • 03/12/2024 11:21:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:05:55 PM
- Acadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of Schizophrenia • Business Wire • 03/11/2024 08:05:00 PM
- Acadia Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference on March 6, 2024 • Business Wire • 02/29/2024 02:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:13:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:10:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:07:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:02:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:16:24 PM
- Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview • Business Wire • 02/27/2024 09:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 02/21/2024 09:05:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 12:08:13 PM
- Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 • Business Wire • 02/13/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 10:09:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 10:05:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 02:55:00 AM
- Acadia Announces Additions to Executive Team • Business Wire • 01/31/2024 01:48:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 10:25:22 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 01/19/2024 09:05:00 PM
- Acadia Announces the Passing of Former President Srdjan (Serge) Stankovic • Business Wire • 01/18/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 11:00:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 11:00:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 11:00:29 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM